FIG 2. One year after discontinuation of etanercept, the patient developed new diplopia, gaze deficit, and left cranial nerve III palsy. Shown is an axial T2-weighted image at level of the midbrain, revealing a demyelinating lesion centered in the left periaqueductal region, in proximity to the oculomotor nucleus.